Back to Search
Start Over
Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes.
- Source :
-
Primary care diabetes [Prim Care Diabetes] 2023 Oct; Vol. 17 (5), pp. 526-528. Date of Electronic Publication: 2023 Jul 31. - Publication Year :
- 2023
-
Abstract
- Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.<br />Competing Interests: Declaration of Competing Interest All authors declare that there are no conflicts of interest concerning the research, authorship, and/or publication of this manuscript.<br /> (Copyright © 2023 Primary Care Diabetes Europe. All rights reserved.)
- Subjects :
- Humans
Risk Factors
Heart Disease Risk Factors
Lipids
Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects
Diabetes Mellitus, Type 1 diagnosis
Diabetes Mellitus, Type 1 drug therapy
Cardiovascular Diseases diagnosis
Cardiovascular Diseases epidemiology
Cardiovascular Diseases etiology
Dyslipidemias diagnosis
Dyslipidemias drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1878-0210
- Volume :
- 17
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Primary care diabetes
- Publication Type :
- Academic Journal
- Accession number :
- 37532667
- Full Text :
- https://doi.org/10.1016/j.pcd.2023.07.005